APPLICATION
ANDA075844
TYPE
ANDA
ORIGINAL APPROVAL
2002-01-03
LATEST ACTION
2007-08-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
OXAPROZINDiscontinued
OXAPROZIN 600MG · TABLET · ORAL
Approval history
2007-08-09Labeling · Supplement 11AP
2007-06-19Labeling · Supplement 10AP
2006-06-08Labeling · Supplement 9AP
2006-02-07Labeling · Supplement 8AP
2003-03-21Labeling · Supplement 6AP
2002-06-12Manufacturing (CMC) · Supplement 1AP
2002-01-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.